Colivelin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2018
012320052018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Alzheimer's disease (AD) is the most common cause of dementia, and effective therapeutics are lacking. Colivelin (CLN), a novel… (More)
Is this relevant?
2016
2016
BACKGROUND Alzheimer's disease (AD) is characterized with progressive memory loss and severe cognitive impairments, which affect… (More)
Is this relevant?
2015
2015
Amyloid β peptide (Aβ) has been thought to be neurotoxic and responsible for the impairment of learning and memory in Alzheimer's… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Elevation of intracranial soluble amyloid-β (Aβ) levels has been implicated in the pathogenesis of Alzheimer's disease (AD… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 6
  • figure 7
Is this relevant?
2009
2009
Fetal alcohol exposure is known to induce cell death through apoptosis. We found that colivelin (CLN), a novel peptide with the… (More)
Is this relevant?
2008
2008
Humanin (HN) and its derivatives, such as Colivelin (CLN), suppress neuronal death induced by insults related to Alzheimer's… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
A 24-amino acid long peptide, Humanin, protects neurons from Alzheimer's disease (AD)-related cell toxicities at sub-nM-uM… (More)
Is this relevant?
2008
2008
Humanin (HN) and its analogues have been shown to protect cells against death induced by various Alzheimer's disease (AD) genes… (More)
Is this relevant?
2006
2006
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease for which there is no sufficiently effective therapy… (More)
Is this relevant?
2005
2005
Alzheimer's disease (AD) is the most common cause of dementia. Humanin (HN) is a short bioactive peptide abolishing neuronal cell… (More)
Is this relevant?